UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

Artificial Neural Network Model of Survival in Patients Treated With Irradiation With and Without Concurrent Chemotherapy for Advanced Carcinoma of the Head and Neck

International journal of radiation oncology, biology, physics, 1998-05, Vol.41 (2), p.339-345

1998

Volltextzugriff (PDF)

CALGB 100801 (Alliance): A Phase II Multi-Center NCI Cooperative Group Study of the Addition of Azacitidine (AZA) to Reduced-Intensity Conditioning (RIC) Allogeneic Transplantation for High Risk Myelodysplasia (MDS) and Older Patients with Acute Myeloid Leukemia (AML): Results of a “test dose” Strategy to Target Busulfan Exposure

Blood, 2014-12, Vol.124 (21), p.543-543

2014

Volltextzugriff (PDF)

Comparison of a novel assay for breast cancer mucin to CA15-3 and carcinoembryonic antigen

Journal of clinical oncology, 1992-07, Vol.10 (7), p.1057-1065

1992

Volltextzugriff (PDF)

Effects of granulocyte-macrophage colony stimulating factor produced in Chinese hamster ovary cells (regramostim), Escherichia coli (molgramostim) and yeast (sargramostim) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy

European journal of haematology, 1995-11, Vol.55 (5), p.348-356

1995

Volltextzugriff (PDF)

Effects of granulocyte-macrophage colony stimulating factor produced in Chinese hamster ovary cells (regramostim), Escherichia coli (molgramostim) and yeast (sargramostim) on priming peripheral blood progenitor cells for use with autologous Done marrow after high-dose chemotherapy

European journal of haematology, 1995-05, Vol.54 (5), p.281-287

1995

Volltextzugriff (PDF)

Feasibility of Administering Oblimersen (G3139; Genasense) with Imatinib Mesylate in Patients with Imatinib Resistant Chronic Myeloid Leukemia (CML) - Cancer and Leukemia Group B Study 10107

Blood, 2005-11, Vol.106 (11), p.1097-1097

2005

Volltextzugriff (PDF)

Flaxseed Supplementation (Not Dietary Fat Restriction) Reduces Prostate Cancer Proliferation Rates in Men Presurgery

Cancer epidemiology, biomarkers & prevention, 2008-12, Vol.17 (12), p.3577-3587

2008

Volltextzugriff (PDF)

A FORMAL DYNAMIC MODEL OF THE DEVELOPMENT OF PURKINJE DENDRITIC SPINES

Mathematical and Computational Methods in Physiology, 1981, p.239-243

1981

Volltextzugriff (PDF)

HYDROCORTISONE (H) WITH OR WITHOUT MITOXANTRONE (M) IN MEN WITH HORMONE REFRACTORY PROSTATE CANCER (HRPC). THE RESULTS OF CALGB 9182

The Journal of urology, 1999-04, p.176

1999

Volltextzugriff (PDF)

Hydrocortisone With or Without Mitoxantrone in Men With Hormone-Refractory Prostate Cancer: Results of the Cancer and Leukemia Group B 9182 Study

Journal of clinical oncology, 1999-08, Vol.17 (8), p.2506-2513

1999

Volltextzugriff (PDF)

Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck Cancer

The New England journal of medicine, 1998-06, Vol.338 (25), p.1798-1804

1998

Volltextzugriff (PDF)

Increased life expectancy resulting from addition of L-deprenyl to madopar® treatment in Parkinson's disease: a longterm study

Journal of Neural Transmission, 1985-06, Vol.64 (2), p.113-127

1985

Volltextzugriff (PDF)

Orthogonal transforms of the Lorenz- and Rössler-equation

Physica. D, 1986, Vol.19 (1), p.135-144

1986

Volltextzugriff (PDF)

P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808

Blood, 2010-09, Vol.116 (9), p.1413-1421

2010

Volltextzugriff (PDF)

Phase I Clinical Study of Fish Oil Fatty Acid Capsules for Patients with Cancer Cachexia: Cancer and Leukemia Group B Study 9473

Clinical cancer research, 1999-12, Vol.5 (12), p.3942-3947

1999

Volltextzugriff (PDF)

A phase II multi-center study of the addition of azacitidine to reduced-intensity conditioning allogeneic transplantation for high-risk myelodysplasia (and older patients with acute myeloid leukemia: CALGB 100801 (Alliance)

Biology of blood and marrow transplantation, 2019-06, Vol.25 (10), p.1984-1992

2019

Volltextzugriff (PDF)

A Phase II Multicenter Study of the Addition of Azacitidine to Reduced-Intensity Conditioning Allogeneic Transplant for High-Risk Myelodysplasia (and Older Patients with Acute Myeloid Leukemia): Results of CALGB 100801 (Alliance)

Biology of blood and marrow transplantation, 2019-10, Vol.25 (10), p.1984-1992

2019

Volltextzugriff (PDF)

phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804

Cancer chemotherapy and pharmacology, 2009-04, Vol.63 (5), p.859-864

2009

Volltextzugriff (PDF)

Phase III Intergroup Study of Lenalidomide Versus Placebo Maintenance Therapy Following Single Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple Myeloma: CALGB 100104

Blood, 2010-11, Vol.116 (21), p.37-37

2010

Volltextzugriff (PDF)

Phase III Trial of Immunotherapy with Recombinant Interleukin-2 (rIL-2) Versus Observation in Patients < 60 Years with Acute Myeloid Leukemia (AML) in First Remission (CR1): Preliminary Results from Cancer and Leukemia Group B (CALGB) 19808

Blood, 2007-11, Vol.110 (11), p.157-157

2007

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(40)
Buchkapitel
(1)

Sprache

Englisch
(41)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(19)
Science & Technology
(19)
Life Sciences & Biomedicine
(18)
Male
(15)
Middle Aged
(15)
Female
(14)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Aged
(11)
Adult
(10)
Oncology
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)
Treatment Outcome
(6)
Disease-Free Survival
(5)
Tumors
(5)
Chemotherapy
(4)
Hematologic And Hematopoietic Diseases
(4)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(4)
Pharmacology. Drug Treatments
(4)
Survival Rate
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Artificial Neural Network Model of Survival in Patients Treated With Irradiation With and Without Concurrent Chemotherapy for Advanced Carcinoma of the Head and Neck

Comparison of a novel assay for breast cancer mucin to CA15-3 and carcinoembryonic antigen

Effects of granulocyte-macrophage colony stimulating factor produced in Chinese hamster ovary cells (regramostim), Escherichia coli (molgramostim) and yeast (sargramostim) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy

Effects of granulocyte-macrophage colony stimulating factor produced in Chinese hamster ovary cells (regramostim), Escherichia coli (molgramostim) and yeast (sargramostim) on priming peripheral blood progenitor cells for use with autologous Done marrow after high-dose chemotherapy

Feasibility of Administering Oblimersen (G3139; Genasense) with Imatinib Mesylate in Patients with Imatinib Resistant Chronic Myeloid Leukemia (CML) - Cancer and Leukemia Group B Study 10107

Flaxseed Supplementation (Not Dietary Fat Restriction) Reduces Prostate Cancer Proliferation Rates in Men Presurgery

A FORMAL DYNAMIC MODEL OF THE DEVELOPMENT OF PURKINJE DENDRITIC SPINES

HYDROCORTISONE (H) WITH OR WITHOUT MITOXANTRONE (M) IN MEN WITH HORMONE REFRACTORY PROSTATE CANCER (HRPC). THE RESULTS OF CALGB 9182

Hydrocortisone With or Without Mitoxantrone in Men With Hormone-Refractory Prostate Cancer: Results of the Cancer and Leukemia Group B 9182 Study

Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck Cancer

Increased life expectancy resulting from addition of L-deprenyl to madopar® treatment in Parkinson's disease: a longterm study

Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma

Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma

Orthogonal transforms of the Lorenz- and Rössler-equation

P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808

Phase I Clinical Study of Fish Oil Fatty Acid Capsules for Patients with Cancer Cachexia: Cancer and Leukemia Group B Study 9473

A phase II multi-center study of the addition of azacitidine to reduced-intensity conditioning allogeneic transplantation for high-risk myelodysplasia (and older patients with acute myeloid leukemia: CALGB 100801 (Alliance)

A Phase II Multicenter Study of the Addition of Azacitidine to Reduced-Intensity Conditioning Allogeneic Transplant for High-Risk Myelodysplasia (and Older Patients with Acute Myeloid Leukemia): Results of CALGB 100801 (Alliance)

A Phase II Study of Allogeneic Transplantation for Older Patients with AML in First Complete Remission Using a Reduced Intensity Conditioning Regimen: Results From CALGB 100103/BMT CTN 0502

phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804

Phase III Intergroup Study of Lenalidomide (CC-5013) Versus Placebo Maintenance Therapy Following Single Autologous Stem Cell Transplant for Multiple Myeloma (CALGB 100104): Initial Report of Patient Accrual and Adverse Events

Phase III Intergroup Study of Lenalidomide Versus Placebo Maintenance Therapy Following Single Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Multiple Myeloma: CALGB 100104

Phase III Trial of Immunotherapy with Recombinant Interleukin-2 (rIL-2) Versus Observation in Patients < 60 Years with Acute Myeloid Leukemia (AML) in First Remission (CR1): Preliminary Results from Cancer and Leukemia Group B (CALGB) 19808

Suchergebnisse filtern